Quality Choice Dandruff 2 In 1 Lotion/shampoo
NDC Package 83324-321-13
Package Information
Quality Choice Dandruff 2 In 1 (pyrithione zinc) lotion/shampoos is shake before usewet hair, massage onto scalp, rinse and repeat if desiredfor best results use at least twice a week or as directed by a doctorfor maximum dandruff control, use every time when you want to shampoo. This formulation utilizes a lotion/shampoo delivery system. Marketed by Chain Drug Marketing Association, Inc., this product is identified by NDC 83324-321 and is authorized under FDA application M032.
Identification & Billing
- RxCUI: 209884 - zinc pyrithione 1 % Medicated Shampoo
- RxCUI: 209884 - zinc pyrithione 10 MG/ML Medicated Shampoo
- RxCUI: 209884 - zinc pyrithione 1 % Medicated Conditioner
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83324 - Chain Drug Marketing Association, Inc.
- 83324-321 - Quality Choice Dandruff 2 In 1
- 83324-321-13 - 399 mL in 1 BOTTLE, PLASTIC
- 83324-321 - Quality Choice Dandruff 2 In 1
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83324-321-13 identifies a specific commercial package of 399 ml in 1 bottle, plastic of Quality Choice Dandruff 2 In 1, a human over the counter drug labeled by Chain Drug Marketing Association, Inc.. This lotion/shampoo is formulated for topical use and contains pyrithione zinc as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chain Drug Marketing Association, Inc. on January 23, 2025. The current certification is valid through December 31, 2026.
How is this Chain Drug Marketing Association, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83324032113. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.